Abstract
Mitochondria are eukaryotic organelles that play a crucial role in several cellular processes, including energy production, β-oxidation of fatty acids and regulation of calcium homeostasis. In the last 20 years there has been a hightened interest in the study of mitochondria following the discoveries that mitochondria are central to the process of programmed cell death and that mitochondrial dysfunctions are implicated in numerous diseases including a wide range of neurological disorders such as Parkinson’s disease, Alzheimer’s disease, Huntington’s disease and amyotrophic lateral sclerosis. In order to identify and study changes in mitochondrial function related to specific neurological conditions the mitochondria are often isolated from the compartment of the central nervous system most affected during disease. Here, we describe a protocol for the isolation of mitochondria from mouse spinal cord, a compartment of the central nervous system that is significantly affected in neuromuscular diseases such as amyotrophic lateral sclerosis. This method relies on differential centrifugation to separate the mitochondria from the other subcellular compartments.
Materials and Reagents
Isoflurane (Isosol) (Vedco, catalog number: 50201)
Fatty acid (FA) free bovine serum albumin (Sigma-Aldrich, catalog number: 85041C)
cOmplete™ ULTRA protease inhibitor tablets, EDTA-free (Roche, catalog number: 0589253001)
OptiPrep™ density gradient medium (Sigma-Aldrich, catalog number: D1556)
Bradford reagent (Bio-Rad, catalog number: 500-0001)
Mannitol (Sigma-Aldrich, catalog number: M4125)
Phosphate buffer saline (PBS) (see Recipes)
1 M Tris-HCl (see Recipes)
0.5 M EDTA (see Recipes)
Buffer M (see Recipes)
Buffer M + 0.45% FA free BSA + protease inhibitors (see Recipes)
Buffer M + protease inhibitors (see Recipes)
Equipment
-
10 ml disposable plastic syringe fitted (heat sealed) with a 200 μl pipette tip
Using a Bunsen burner, heat and partially melt the wide end of a 200 μl pipette tip. Before the plastic has time to harden quickly insert the melted end of the 200 μl pipette tip into the luer-lok of a disposable plastic 10 ml syringe. Let the assembly cool and check the tightness of the seal by running 10 ml of water at high pressure through the syringe/tip assembly.
Sharp heavy dissection duty scissors
Euthanasia jar
Balance and plastic weight boat
Tweezers
1 ml glass homogenizer with loose and tight pestles (Kimble Chase Kontes) (Fisher Scientific, catalog number: 885300-0001)
Table top refrigerated centrifuge
Ultrafuge
Thinwall, Ultra-Clear™ 5 ml 13 × 51 mm ultrafuge tubes (Beckman Coulter, catalog number: 344057)
SW55Ti swing-out rotor (Beckman Coulter, model: 342194)
Pipettes
50 ml conical
Procedure
A. Preparation
-
Put the following items on ice:
Homogenizer + pestles (those should be placed in a 50 ml conical on ice)
50 ml of Buffer M + 0.45% BSA + cOmplete™
50 ml of Buffer M + cOmplete™
-
Transfer the following items to the cold room:
-
All the items placed on ice.
Pipettes
Pipette tips
Tweezers
Small bucket of water to rinse pestles
Swing out buckets for SW55Ti
UltraClear SW55Ti tubes
OptiPrep
-
-
Set up the animal dissection area with:
Euthanasia chamber with Isoflurane
Heavy duty scissors
10 ml syringe filled with PBS
Small plastic weigh trays placed on ice
Tweezers
B. The start of procedure
Terminally anesthetize the mouse using isoflurane in the euthanasia chamber.
Cervicaly dislocate the animal, decapitate and section the spinal column at the iliac crest (just above the hips). Flush the spinal cord from the spinal column using the 10 ml syringe filled with PBS. Insert the tip at the caudal opening of the spinal column and eject about 5 ml of PBS. This should flush out the spinal cord from the rostral end of the severed spinal column. If a clean flushing of the spinal cord cannot be achieved, section the dorsal column below the front limbs and repeat the flushing procedure. In this case make sure to save the piece of spinal cord located within the small piece of spinal column resulting from the cut below the front-limbs. Place the spinal cord, after removing excess PBS, in the small plastic weigh trays placed on ice.
Weigh the spinal cord rapidly and place it back on ice.
Steps B5 to B18 are all performed in the cold room.
While working in the cold room, transfer the spinal cord with cold tweezers in the 1 ml glass homogenizer on ice. Add 10 volumes of buffer M + 0.45% FA free BSA + cOmplete™ (e.g. if the spinal cord weighs 60 mg add 600 μl of buffer).
-
Gently homogenize the tissue on ice with 10–15 strokes (just enough to completely dissociate the tissue) using the cooled loose pestle. Avoid forming air bubbles.
Note: Generating bubbles during the homogenization process can lead to disruption of intracellular membranes and denaturing of proteins, both of which should be avoided to reduce damage to the mitochondria.
Gently Homogenize the tissue on ice with 15 strokes using the tight pestle. Avoid forming air bubbles.
-
Centrifuge at 1,000 × g for 5 min at 4 °C and transfer the supernatant (S1) to a fresh tube on ice.
Note: The 1,000 × g supernatant generated at this step is composed mostly of cytosol with heavy and light membranes. The pellet contains mostly unbroken cells and nuclei.
-
Resuspend the pellet (P1) in 10 volumes of buffer M + 0.45% FA free BSA + cOmplete™ and gently homogenize 15x using the tight pestle. Avoid forming air bubbles.
Note: This step is used to further release cytosol and intracellular organelles from the remaining unbroken cells.
Centrifuge at 1,000 × g for 5 min at 4 °C and pool the resulting supernatant (S1) with the supernatant (S2) from the step 8.
-
Centrifuge the pooled supernatants at 1,000 × g for 5 min at 4 °C.
Note: This step ensures that any contaminating unbroken cells or nuclei are removed from the cytosol/intracellular membrane subcellular fraction.
Collect supernatant (S3) staying clear of the pellet and spin it at 12,000 × g for 10 min at 4 °C.
Prepare Beckman UltraClear™ tubes with 200 μl of OptiPrep™ and 600 μl of Buffer M + 0.45% FA free BSA + cOmplete™. Mix well and store on ice.
-
Discard the supernatant (S4) resulting from step B12 and gently (but thoroughly) resuspend the pellet (P4) using in 150 μl of buffer M + 0.45% FA free BSA + cOmplete™.
Note: The 12,000 × g supernatant generated at this step is composed mostly of cytosol with light membranes. The pellet contains mostly heavy intracellular membranes (mitochondria).
Once the pellet is completely resuspended transfer all of it (recording the final volume) into the Beckman UltraClear™ tubes prepared in step B13. Complement with buffer M + 0.45% FA free BSA + cOmplete™ to make a final volume of 1 ml and mix gently (but thoroughly) with a 1 ml pipette.
-
Transfer the UltraClear™ tubes to the SW55Ti swing out buckets on ice and centrifuge the tubes in a SW55Ti rotor using a high speed centrifuge at 17,000 × g (equivalent to 13,400 rpm) at 4 °C for 17 min (remove breaks).
Note: The heavy membrane fraction is centrifuged in an OptiPrep gradient to remove most of the contaminants (for example myelin and endoplasmic reticulum) from the heavy membrane preparation. The UltraClear™ tubes can be reused if washed well after use (without detergent) and stored dry.
Gently remove the tubes from the buckets and place them on ice. Using gentle aspiration remove supernatant including the top white layer.
-
Gently resuspend the pellet (P5) in 1 ml of buffer M + cOmplete (without completely dispersing it) and centrifuge at 12,000 × g for 10 min at 4 °C.
Note: After the OptiPrep gradient the heavy membranes are resuspended in buffer M without BSA so as to wash off the BSA from the previous steps to more accurately measure the protein concentration in step B20.
-
Resuspend the pellet (P6) in 10–20 μl of buffer M + cOmplete™ by gently flicking the tube with your fingers and placing back on ice as quickly as possible. Make sure pellet is completely resuspended before performing the protein quantification.
Note: It is important to resuspend the heavy membranes at a high concentration since this reduces damage to the organelles. Resuspending the organelles by flicking also reduces organelle damage.
-
Estimate protein quantity using a Bradford assay on 1 μl of resuspended pellet. Once the protein concentration is determined, add a final concentration of 0.45% FA free BSA to the suspension using a 4.5% FA free BSA stock to avoid diluting the preparation.
Note: FA free BSA is added back to the heavy membrane preparation after protein quantification to allow for better preservation of mitochondrial activity by reducing uncoupling of the organelle. Ideally mitochondrial activity (oxygen consumption) should be measured on a fraction of the preparation to determine the quality of the organelle and the damage that may have been sustained during preparation.
Recipes
-
PBS (1 L)
Start with 800 ml of distilled water
Add 8 g of NaCl
Add 0.2 g of KCl
Add 1.44 g of Na2HPO4
Add 0.24 g of KH2PO4
Adjust the pH to 7.4 with HCl
Add distilled water to a total volume of 1 L
-
1 M Tris-HCl, pH 7.4 (500 ml)
Mix 60.57 g of Tris base with 400 ml of dH2O
When Tris base is dissolved pH to 7.4 using concentrated HCl
Complete to 500 ml with dH2O
Stored at 4 °C
-
0.5 M EDTA, pH 8.0 (500 ml)
Mix 73.06 g of EDTA with 400 ml of dH2O
Adjust pH to 8.0 using concentrated KOH
Complete to 500 ml with dH2O
Stored at 4 °C
-
Buffer M (500 ml)
Mix 19.1 g of mannitol into 400 ml of dH2O
Add 11.9 g of sucrose
Add 5 ml of 1 M Tris-HCl pH 7.4
Add 1 ml of 0.5 M EDTA pH 8.0
Complete to 500 ml with dH2O
Filter sterilize (0.22 μm)
-
Stored at 4 °C
Note: Before the start of the isolation procedure prepare Recipes 5 and 6.
-
Buffer M + 0.45% FA free BSA + protease inhibitors
50 ml Buffer M + 0.225 g FA free BSA + 1 tablet of cOmplete™ protease inhibitors (stored at 4 °C)
-
Buffer M + protease inhibitors
50 ml Buffer M + 1 tablet of cOmplete™ protease inhibitors (stored at 4 °C)
Acknowledgments
This protocol is adapted from Parone et al. (2013) and Vande Velde et al. (2008).
References
- 1.Parone PA, Da Cruz S, Han JS, McAlonis-Downes M, Vetto AP, Lee SK, Tseng E, Cleveland DW. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. J Neurosci. 2013;33(11):4657–4671. doi: 10.1523/JNEUROSCI.1119-12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Vande Velde C, Miller TM, Cashman NR, Cleveland DW. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci U S A. 2008;105(10):4022–4027. doi: 10.1073/pnas.0712209105. [DOI] [PMC free article] [PubMed] [Google Scholar]